Literature DB >> 3262733

Prognostic factors in acquired immunodeficiency syndrome.

J D Wenger1, C C Whalen, M M Lederman, T J Spech, J T Carey, J W Tomford, C S Landefeld.   

Abstract

To identify prognostic factors in acquired immunodeficiency syndrome (AIDS), the authors studied an inception cohort of 45 patients in a non-endemic area (Group I). The probability of survival was 67% six months after the diagnosis of AIDS and 32% at 12 months. As shown by multivariate Cox regression analysis, survivals were shorter (p less than 0.01) in patients 35 years old or older and in those who had anemia when AIDS was diagnosed. In patients with neither of these poor prognostic factors, the 12-month survival was 64%; in patients with one factor, it was 22%; and in patients with both factors, 0%. The prognostic significance of these two factors was validated in a second inception cohort of 50 patients (Group II): in patients with zero, one, and two poor prognostic factors, the 12-month survivals were 80%, 58%, and 26%, respectively. Other poor prognostic factors in Group I included disseminated Mycobacterium avium-intracellulare and the development of new opportunistic infections or neoplasms. The authors conclude that clinically important prognostic factors can be identified in AIDS patients. These findings should be considered in planning therapeutic trials and in counseling patients.

Entities:  

Mesh:

Year:  1988        PMID: 3262733     DOI: 10.1007/bf02595923

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  26 in total

1.  Age-related changes in the subsets and functions of human T lymphocytes.

Authors:  S Kishimoto; S Tomino; K Inomata; S Kotegawa; T Saito; M Kuroki; H Mitsuya; S Hisamitsu
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

2.  Prognostically significant classification of immune changes in AIDS with Kaposi's sarcoma.

Authors:  J Taylor; R Afrasiabi; J L Fahey; E Korns; M Weaver; R Mitsuysau
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

3.  Length of survival of patients with acquired immune deficiency syndrome in the United Kingdom.

Authors:  G Marasca; M McEvoy
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-28

4.  Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity.

Authors:  F P Siegal; C Lopez; P A Fitzgerald; K Shah; P Baron; I Z Leiderman; D Imperato; S Landesman
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

5.  Mortality associated with mode of presentation in the acquired immune deficiency syndrome.

Authors:  A R Moss; G McCallum; P A Volberding; P Bacchetti; S Dritz
Journal:  J Natl Cancer Inst       Date:  1984-12       Impact factor: 13.506

6.  How to read clinical journals: III. To learn the clinical course and prognosis of disease.

Authors: 
Journal:  Can Med Assoc J       Date:  1981-04-01       Impact factor: 8.262

Review 7.  The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome.

Authors:  B Safai; K G Johnson; P L Myskowski; B Koziner; S Y Yang; S Cunningham-Rundles; J H Godbold; B Dupont
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

8.  Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome.

Authors:  H C Lane; H Masur; E P Gelmann; D L Longo; R G Steis; T Chused; G Whalen; L C Edgar; A S Fauci
Journal:  Am J Med       Date:  1985-03       Impact factor: 4.965

9.  The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study.

Authors:  H W Jaffe; W W Darrow; D F Echenberg; P M O'Malley; J P Getchell; V S Kalyanaraman; R H Byers; D P Drennan; E H Braff; J W Curran
Journal:  Ann Intern Med       Date:  1985-08       Impact factor: 25.391

10.  Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome.

Authors:  C C Hawkins; J W Gold; E Whimbey; T E Kiehn; P Brannon; R Cammarata; A E Brown; D Armstrong
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

View more
  6 in total

1.  Aging in AIDS; AIDS and aging.

Authors:  A C Justice; C Whalen
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

2.  Relationship Between Anemia and Systemic Inflammation in People Living With HIV and Tuberculosis: A Sub-Analysis of the CADIRIS Clinical Trial.

Authors:  Mariana Araújo-Pereira; Beatriz Barreto-Duarte; María B Arriaga; Laura W Musselwhite; Caian L Vinhaes; Pablo F Belaunzaran-Zamudio; Adam Rupert; Luis J Montaner; Michael M Lederman; Irini Sereti; Juan G Sierra Madero; Bruno B Andrade
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

3.  Early HIV detection: a community mental health role.

Authors:  M D Knox; C F Clark
Journal:  J Ment Health Adm       Date:  1991

4.  Lean tissue mass wasting is associated with increased risk of mortality among women with pulmonary tuberculosis in urban Uganda.

Authors:  Ezekiel Mupere; Lashaunda Malone; Sarah Zalwango; Allan Chiunda; Alphonse Okwera; Isabel Parraga; Catherine M Stein; Daniel J Tisch; Roy Mugerwa; W Henry Boom; Harriet Mayanja; Christopher C Whalen
Journal:  Ann Epidemiol       Date:  2012-05-09       Impact factor: 3.797

5.  Delayed diagnosis of human immunodeficiency virus infection in a patient with non-specific neurological symptoms and pancytopenia: a case report.

Authors:  Marcin Moniuszko; Andrzej Moniuszko; Justyna Puciłowska; Karolina Kisluk; Marta Jeznach; Anna Grzeszczuk; Robert Flisiak; Anna Bodzenta-Lukaszyk
Journal:  J Med Case Rep       Date:  2014-03-24

6.  Blood neutrophil counts in HIV-infected patients with cryptococcal meningitis: Association with mortality.

Authors:  Abdu Kisekka Musubire; David B Meya; Joshua Rhein; Graeme Meintjes; Paul R Bohjanen; Edwin Nuwagira; Conrad Muzoora; David R Boulware; Kathy Huppler Hullsiek
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.